Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Baroness Meacher, and are more likely to reflect personal policy preferences.
A Bill to enable adults who are terminally ill to be provided at their request with specified assistance to end their own life; and for connected purposes
A bill to amend the law on marriage to permit authorised belief organisations to solemnise marriages
Baroness Meacher has not co-sponsored any Bills in the current parliamentary sitting
The Government intends to publish the performance data from the Electrification of Heat Demonstration Project in due course, once quality assurance of the data has been completed.
Ofgem uses the price control framework to ensure that electricity network companies are provided with the necessary funding to deliver the required capacity to meet future demand on the grid, including to support the roll out of heat pumps. Government liaises regularly with Ofgem and industry, including network operators, on this issue.
The Government is committed to developing hydrogen as a decarbonised energy carrier, as confirmed in the Ten Point Plan for a Green Industrial Revolution announced by my Rt. Hon. Friend the Prime Minister on 18th November.
The Ten Point Plan package aims to bring forward a combination of commercial-scale CCUS-enabled ‘blue’ hydrogen and smaller scale electrolytic ‘green’ hydrogen projects. Both these production methods – and other innovative techniques – will be needed to deliver UK hydrogen demand expected by 2050.
This twin-track approach will enable production to be brought forward at the necessary scale during the 2020s, to grow the supply chain and build confidence in the sector, whilst scaling up green hydrogen which is likely to dominate the global market in the long term.
The Plan set out that the Government, working with industry, is aiming for 5GW of low carbon hydrogen production capacity in the UK by 2030,
We will support our hydrogen ambition through a range of measures, including a £240m Net Zero Hydrogen Fund out to 2024/25 and bringing forward, next year, detail on hydrogen business models and the revenue mechanism to stimulate private investment in new low carbon hydrogen production facilities. We expect these measures to reflect our twin track approach to production.
The Government is committed to developing hydrogen as a decarbonised energy carrier, as confirmed in the Ten Point Plan for a Green Industrial Revolution announced by my Rt. Hon. Friend the Prime Minister on 18th November.
The Ten Point Plan package aims to bring forward a combination of commercial-scale CCUS-enabled ‘blue’ hydrogen and smaller scale electrolytic ‘green’ hydrogen projects. Both these production methods – and other innovative techniques – will be needed to deliver UK hydrogen demand expected by 2050.
This twin-track approach will enable production to be brought forward at the necessary scale during the 2020s, to grow the supply chain and build confidence in the sector, whilst scaling up green hydrogen which is likely to dominate the global market in the long term.
The Plan set out that the Government, working with industry, is aiming for 5GW of low carbon hydrogen production capacity in the UK by 2030.
We will support our hydrogen ambition through a range of measures, including a £240m Net Zero Hydrogen Fund out to 2024/25 and bringing forward, next year, detail on hydrogen business models and the revenue mechanism to stimulate private investment in new low carbon hydrogen production facilities. We expect these measures to reflect our twin track approach to production. More detail on how we intend to work with industry towards the 5GW 2030 ambition will be set out in the hydrogen strategy in early 2021.
We are following international hydrogen developments from Germany, France and other countries, and participate in a range of international fora, including the Clean Energy Ministerial, the International Partnership for Hydrogen for Fuel Cells in the Economy and Mission Innovation. These offer opportunities to discuss other countries’ domestic hydrogen strategies in detail, their levels of investment, including in green hydrogen production and explore opportunities for collaboration.
We plan to publish a UK Hydrogen Strategy in early 2021; this will be informed in part by assessment of international activity and the opportunities and challenges that presents for the UK hydrogen economy.
The Minister of State for Health and Secondary Care (Will Quince MP) has overall responsibility for cell and gene therapies and the uptake of new treatments in the National Health Service.
The Department of Health and Social Care and the Department of Business, Energy and Industrial Strategy fund research into cell and gene therapies including through the Office for Life Sciences. The Department of Health and Social Care has recently announced the outcome of an open competition for designation and funding of the National Institute for Health and Care Research’s (NIHR) Biomedical Research Centres (BRCs). Of the 20 BRCs, 14 conduct research into cell and gene therapies, which has the potential to address complex diseases, such as motor neurone disease and rare disorders for which there are currently no effective treatments.
Since April 2017, the NIHR has provided £38,623,171 to fund 39 specific research projects. While the NIHR welcomes funding applications for research into any aspect of human health, including cell and gene therapies, it is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.
The Cell and Gene Therapy Catapult, established by Innovate UK, develops the cell and gene therapy industry in the United Kingdom, working with academia and industry to ensure therapies can be used in health services globally. The Catapult has received £75.4 million from the Government in the current five-year funding period until March 2023. The Medical Research Council (MRC) funds the research and development of advanced therapies across its response mode funding schemes and through a number of strategic funding calls. In 2021/22, the MRC funded £33.9 million in research and infrastructure for advanced therapies from discovery research through to translation and clinical trials.
The National Institute for Health and Care Excellence (NICE) has published a guideline Care of dying adults in the last days of life which makes recommendations on maintaining hydration, including taking into account the wishes of the person and discussing the risks and benefits of clinically assisted hydration. NICE has also published Shared decision making, which includes guidance on communicating risks, benefits and consequences. Additionally, NICE’s guideline Decision-making and mental capacity includes recommendations on advance care planning, including helping people to exercise their right to personal autonomy as far as possible. Copies of these guidelines are attached.